He is also a regular guest editor for Frontiers in Public Health, Frontiers in Pediatrics, Frontiers in Pharmacology, Frontiers in Immunology, Nutrients, and Diseases.
Dr Lordan has written editorials for the journals Science, Endocrine Practice, Nutrients, and PharmaNutrition.
Nutraceuticals Editorial Board Appointment:
Special Issue in the International Journal of Molecular Sciences (IJMS) MDPI:
Biology, Physiology, and Clinical Research of Natural Products in Modern Medicine, Translational Science, and Big Data Analyses
This Special Issue is receiving submissions before the deadline of the 20th June 2023
The subject of molecular biology or its technical aspects alone is not helpful for other researchers and practicing clinicians. However, molecular biological aspects and the biological and physiological roles of nutrients and natural compounds in human health would be valuable. Therefore, we expect manuscripts to encompass a broader outlook combining biology, biochemistry, pharmacology, and especially the translational and clinical aspects of molecules of interest.
We also encourage submissions on science-based policy-making processes related to natural products, especially nutrients such as vitamin D, and Big Data analyses related to infections such as COVID-19. Submitted papers will be published online promptly once accepted after rigorous peer review.
Special Issue in Nutraceuticals MDPI:
This Special Issue is receiving submissions before the deadline of the 28th February 2023
Dietary supplements and nutraceuticals are related but distinct nonpharmaceutical products. Nutraceuticals are supplements with purported health benefits that exceed their basic nutritional value. Therefore, the main difference between a nutraceutical and a dietary supplement is that nutraceuticals should not only supplement the diet, but should also contribute to the prophylaxis or treatment of a diseases or disorder. However, defining nutraceuticals is a challenge, so manuscripts describing supplements with potential prophylactic or therapeutic effects are also welcome.
This Special Issue is focused on nutraceuticals and supplements for the prevention and treatment of cardiometabolic diseases. Original articles and reviews aimed at understanding the molecular mechanisms that underpin the actions of nutraceuticals on cardiometabolic disesases are welcome. These include studies relating to atherosclerosis, inflammation, obesity, immune function, platelet function, cholesterol metabolism, and diabetes. In particular, human studies investigating the efficacy of nutraceuticals as preventative and/or therapeutic agents are welcome. Potential topics include but are not limited to nutraceutical actions in cultured cells, animal models, and human subjects that address aspects such as cellular responses, signal transduction, gene expression, intracellular targets, biomarkers and disease severity, and bioavailability among other topics will be considered. Articles related to nutraceutical development, regulation, and market growth are also welcome.
Special Issue in Nutrients MDPI:
Frontiers in Nutrition Research Topic:
The main objective of this Research Topic is to understand the recent advances in in relation to the role of dietary phospholipids and sphingolipids in metabolism and health. This Research Topic will cover topics including: cardiometabolic diseases, inflammation, dietary intervention trials, animal models, mechanisms of disease, and preventative nutrition.
This Research Topic welcomes articles that look to understand the role of dietary phospholipids and sphingolipids in nutrition, metabolism, and health. Specifically, we welcome submissions of original research (including meta-analyses) and review articles focusing on, but not limited to, the following terms:
1. The impact of consuming foods abundant in phospholipids and sphingolipids on metabolism, health and disease prevention
2. Mechanistic studies involving the role of nutrition in the metabolism of phospholipids and sphingolipids and their impact on health.
3. Reviews focused on the state-of-the-art of dietary phospholipids and sphingolipids in metabolism and disease.
Special Issue in Nutrients MDPI:
The world is in the second year of the COVID-19 pandemic. The pandemic continues to have a tremendous impact on society through the direct and indirect effects on health and trying to stay healthy. The primary means being used to reduce the risk of COVID-19 include social distancing, lockdowns, testing and quarantine, wearing masks, cleaning surfaces and atmospheres in closed spaces, and vaccinations. Those who develop COVID-19 may be treated with various drugs, which are still under development. No singular approach can stop the pandemic by itself. The more approaches that are employed, the better the chances are to quell its devastating effects. However, some of the approaches being used, such as lockdowns, have significant adverse effects on people and the economy. In addition, for many underdeveloped countries, the measures employed in the developed countries may not be possible or appropriate to their situations.
This Special Issue seeks manuscripts that address natural approaches related to diet and supplements to reduce the risk of COVID-19 and its effects.
Special Issue in Diseases MDPI:
This Special Issue will provide an open access opportunity to publish research work and review articles related to recent advances in understanding the role of lipids in health and disease and will hopefully present new molecular insights for developing potential therapeutic treatments as well as better patient diagnostic and disease prevention strategies.
Peer Review Experience
- PLoS Medicine
- Advanced Science
- Journal of Translational Medicine
- The Lancet
- Lipids in Health and Disease
- European Journal of Clinical Nutrition
- Frontiers in Nutrition
- British Journal of Nutrition